ZimVie Inc. (ZIMV)
NASDAQ: ZIMV
· Real-Time Price · USD
9.06
0.00 (0.00%)
At close: May 01, 2025, 3:31 PM
0.00% (1D)
| Bid | 8.98 |
| Market Cap | 252.3M |
| Revenue (ttm) | 449.75M |
| Net Income (ttm) | -15.57M |
| EPS (ttm) | -1.23 |
| PE Ratio (ttm) | -7.37 |
| Forward PE | 9.99 |
| Analyst | Buy |
| Ask | 9.07 |
| Volume | 79,590 |
| Avg. Volume (20D) | 136,813 |
| Open | 9.25 |
| Previous Close | 9.06 |
| Day's Range | 8.92 - 9.27 |
| 52-Week Range | 8.56 - 22.40 |
| Beta | 2.00 |
About ZIMV
ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and vir...
Industry Medical - Devices
Sector Healthcare
IPO Date Feb 16, 2022
Employees 1,770
Stock Exchange NASDAQ
Ticker Symbol ZIMV
Website https://www.zimvie.com
Analyst Forecast
According to 1 analyst ratings, the average rating for ZIMV stock is "Buy." The 12-month stock price forecast is $23, which is an increase of 153.86% from the latest price.
Stock ForecastsNext Earnings Release
ZimVie Inc. is scheduled to release its earnings on May 8, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-5.3%
ZimVie shares are trading lower after Needham down...
Unlock content with
Pro Subscription
9 months ago
-15.2%
ZimVie shares are trading lower after the company reported worse-than-expected Q2 adjusted EPS results.
